Xaira Therapeutics
Founded Year
2023Stage
Series A | AliveTotal Raised
$1BLast Raised
$500M | 5 mos agoAbout Xaira Therapeutics
Xaira Therapeutics focuses on revolutionizing drug research and development within the biopharmaceutical industry through the use of artificial intelligence. The company offers a platform designed to enhance the drug discovery process, aiming to streamline and improve the efficiency of developing new therapeutics. Xaira Therapeutics primarily serves the biopharmaceutical sector with innovative solutions to accelerate drug R&D. It was founded in 2023 and is based in San Francisco, California.
Loading...
ESPs containing Xaira Therapeutics
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The generative AI — protein & drug design tools market offers solutions that aim to accelerate and de-risk the drug development process. By using generative AI, companies can significantly reduce the time and cost of drug discovery, expedite the development cycle to design next-generation therapeutics and vaccines, and engineer proteins with fewer experiments. These technologies can increase the a…
Xaira Therapeutics named as Highflier among 15 other companies, including Insilico Medicine, Cradle, and InstaDeep.
Loading...
Expert Collections containing Xaira Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Xaira Therapeutics is included in 4 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,244 items
Artificial Intelligence
14,769 items
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
Generative AI
863 items
Companies working on generative AI applications and infrastructure.
Digital Health
11,068 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Latest Xaira Therapeutics News
Sep 3, 2024
Exploring the Top AI Fundings of 2024: Key Investments Shaping AI Startups Copied The year 2024 has been a groundbreaking period for AI startups, with unprecedented levels of funding pouring into the sector. Investors, recognizing the transformative potential of artificial intelligence, have directed billions of dollars into companies that promise to revolutionize industries ranging from healthcare and finance to robotics and data security. This article delves into the top AI fundings of 2024, highlighting the AI startups that have secured significant investments and are pushing the boundaries of AI architectures. These companies are not only attracting substantial AI investments but are also leading the charge in developing innovative AI architectures and solutions. The Landscape of AI Investments in 2024 AI has become a cornerstone of modern technology, driving advancements in various sectors. The influx of capital into AI startups in 2024 underscores the growing importance of AI architectures in addressing complex challenges. From conversational AI to AI-powered drug discovery, the scope of applications is vast. This surge in AI investments has led to the development of more sophisticated AI architectures, which in turn, are enabling companies to create cutting-edge solutions. 1. xAI - Burlingame, Calif. 2024 Amount Raised: US$6 Billion xAI led by Elon Musk has taken the credit of being the most funded AI start-up in the year 2024 with US$6 billion in Series B funding round. The latest funding round featuring big shots like Andreessen Horowitz, Sequoia Capital, and Prince Alwaleed Bin Talal of Saudi Arabia is based on huge faith in Musk’s vision for AI surfacers. The funds are for growing xAI’s product portfolio and for deploying state-of-the-art AI platforms, as well as for deepening research on revolutionary AI architectures. Groak conversational AI, which intends to compete with current AI models at xai, is set to demonstrate the extent of the programs’ continuing development. 2. Anthropic - San Francisco 2024 Amount Raised: US$2.75 Billion Anthropic, a startup launched by Daniela and Dario Amodei, is already backed to the tune of US$2.75 billion in 2024, which will extend its superiority in artificial intelligence research and development. Amazon’s US$20 million cheque is part of its umbrella US$4 billion future for Anthropic, which confirms the company’s relevance to the development of AI architectures, and its future as a potential driver of future AI investments. Anthropic’s Claude 3 model family with a special focus on Claude 3. 5 Sonnet, provides an idea that the company is pushing for the development of better AI in different areas including content creation and code generation. 3. Xaira Therapeutics - San Francisco CEO: Marc Tessier-Lavigne 2024 Amount Raised: US$1 Billion Xaira Therapeutics has caused ripples in the pharmaceutical sector by securing US$1 billion inbound capital for applying AI to drug R&D. The startup’s goal is to create a platform that will utilize innovative machine learning capability to transform therapeutic research. The monster jumps for ARCH Venture Partners and Foresite Capital should be seen in light of the increasing importance of AI architectures in the exploration of new paradigms in biosciences. The way Xaira has chosen his path for AI advancement in the drug development industry is going to leave a long-term footprint on the healthcare system. 4. Figure AI - Sunnyvale, Calif. CEO: Brett Adcock 2024 Amount Raised: US$675 Million Figure AI, known for developing autonomous humanoid robots, raised US$675 million in a Series B round from investors including Microsoft and Nvidia. The collaboration between Figure AI and OpenAI to enhance humanoid robots' capabilities highlights the intersection of AI architectures with robotics. This substantial funding will be used to scale AI training, expand manufacturing capabilities, and accelerate commercial deployment. Figure AI’s focus on creating commercially viable autonomous robots is a significant leap forward in AI applications in robotics. 5. Cyera - New York 2024 Amount Raised: US$300 Million Cyera, an AI development in data security, has raised US$300 million in Series C funding. The startup’s AI platform enables enterprises to search, understand, and protect their information assets, which is a dire need in this digital world. The investment by Coatue and Spark Capital fund indicates how AI architectures improve data security measures. Cyera has no agents and overhead hence proving the effectiveness of how AI turns data into value. 6. Augment - Palo Alto, Calif. CEO: Scott Dietzen 2024 Amount Raised: US$227 Million Augment, an AI startup that is concerned with coding assistance technology bagged US$227 million in financing under Series B. The artificial intelligence of the startup can decrease a large codebase and safeguard the intellectual property of their customers and thus it has been backed by investments from AI giants like Sutter Hill Ventures and Index Ventures. The way Augment differentiates its product from others, meaning the AI model faces real objects and no fake elements, is a trend in software development; thus it points out the AI's capability to proceed to AI-based systems in programming that help efficiency and accuracy. 7. Glean - Palo Alto, Calif. CEO: Arvind Jain 2024 Amount Raised: US$200 Million The enterprise AI platform Glean collected US$200 million during the stretch to increase the capabilities of the no-code custom generative AI agents and chatbots. The system, to be precise, which gives indisputable data-based answers, is the brainchild of those developers who threw in money together with similarly interested investors of the caliber of Kleiner Perkins and Sequoia Capital. In case you'd like to have a look at how you can use Glean AI scripts which are used in the company to ensure good decisions and the productivity of the business. 8. Cognition AI - San Francisco CEO: Scott Wu 2024 Amount Raised: US$196 Million Cognition AI, the creator of Devin, an autonomous AI software engineer, raised US$196 million in 2024. Devin’s capabilities, ranging from code deployment to model fine-tuning, have positioned Cognition AI as a leader in AI-driven software engineering . The funding, led by investors such as Kleiner Perkins and Lightspeed Ventures, underscores the growing demand for AI architectures that can automate complex engineering tasks. 9. Celestial AI - Santa Clara, Calif. CEO: Dave Lazovsky 2024 Amount Raised: US$175 Million Celestial AI , a company that focuses on Photonic Fabric which is a technology based on optical interconnect, closed a Series C round with a whopping US$175 million. The start-up’s technology dismantles computing and memory, making it possible to have higher bandwidth and less delay. The AI investments from the U.S. Innovative Technology Fund and AMD Ventures highlight the potential of AI architectures in revolutionizing data processing and transmission. Celestial AI’s innovative approach to optical interconnects is poised to make a significant impact on AI and data centers. 10. Perplexity AI - San Francisco CEO: Aravind Srinivas 2024 Amount Raised: US$136.3 Million Perplexity AI , known for its AI-powered answer engine, raised US$136.3 million in 2024. The startup’s technology provides conversational, verifiable information with citations, making it a valuable tool for both consumers and businesses. The AI investments from Amazon founder Jeff Bezos and Nvidia underscore the growing importance of AI architectures in delivering accurate and reliable information. Perplexity AI’s Enterprise Pro offering, aimed at business-to-business applications, is set to expand the startup’s reach in the AI market. Conclusion The year 2024 is considered the year of huge AI investments as many billions of dollars have gone into AI startups thus making them the stars of what AI can realize. These leading AI investments are not only money supply resources; they are the initial blow-up of the fortified wall of the most groundbreaking AI architectures that allow for the solving of several issues, delivering innovation, and opening new doors in different businesses. The AI development will have a very long life all over the digging to the fashion of nature. For now, these startups promise to be major players in the future of technology. FAQs 1. What are the top AI fundings of 2024? The top AI fundings of 2024 include xAI, Anthropic, Xaira Therapeutics, Figure AI, and Cyera, among others. 2. Why is AI funding important? AI funding is crucial for developing new AI architectures, scaling innovative solutions, and driving the adoption of AI across various industries. 3. Which sectors will benefit from AI investments in 2024? Sectors such as healthcare, robotics, data security, and software engineering are major beneficiaries of AI investments in 2024. 4. What role do AI architectures play in these investments? AI architectures are central to these investments, enabling startups to create sophisticated AI solutions that address complex challenges. 5. Who are the key investors in AI startups in 2024? Key investors include Andreessen Horowitz, Sequoia Capital, Amazon, Microsoft, and Nvidia, among others.
Xaira Therapeutics Frequently Asked Questions (FAQ)
When was Xaira Therapeutics founded?
Xaira Therapeutics was founded in 2023.
Where is Xaira Therapeutics's headquarters?
Xaira Therapeutics's headquarters is located at San Francisco.
What is Xaira Therapeutics's latest funding round?
Xaira Therapeutics's latest funding round is Series A.
How much did Xaira Therapeutics raise?
Xaira Therapeutics raised a total of $1B.
Who are the investors of Xaira Therapeutics?
Investors of Xaira Therapeutics include Foresite Capital, ARCH Venture Partners, SV Angel, Lightspeed Venture Partners, RSquared and 11 more.
Loading...
Loading...